Showing results (121-130 of 195) with videos related to
Sort By:
Pageof 20
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.Practical Laboratory Medicine|November 4, 2020
Effective interventions to improve the quality of critically high point-of-care glucose meter resultsJulie Lv Shaw, Christopher R McCudden, David A Colantonio, et al.Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.Cancer Research|March 26, 2002
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technologyChristophe Rosty, Laurence Christa, Scott Kuzdzal, et al.Theranostics|November 18, 2020
Urinary glycoproteins associated with aggressive prostate cancerMingming Dong, T Mamie Lih, Shao-Yung Chen, et al.Journal of the National Cancer Institute|November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancerHsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.Journal of Hematology & Oncology|December 8, 2020
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targetsYangying Zhou, T Mamie Lih, Jianbo Pan, et al.Theranostics|May 17, 2021
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancerJin Song, Shiyong Ma, Lori J Sokoll, et al.Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2012
Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassayLori J Sokoll, Daniel W Chan, George G Klee, et al.Pageof 20